Pemetrexed plus Platinum Chemotherapy with or Without Immunotherapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Govindan, R. [1 ]
Borghaei, H. [2 ]
He, S. [3 ]
Kim, J. S. [3 ]
Papadimitrakopoulou, V. [4 ]
机构：
[1] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO USA
[2] Fox Chase Canc Ctr, Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Texas MD Anderson Canc Ctr, Orac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
safety profile; Immunotherapy; pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-040
引用
收藏
页码：S2083 / S2084
页数：2
相关论文
共 50 条
  • [1] Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis
    Li, X.
    Li, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2084 - S2084
  • [2] COMPARISON OF EFFICACY OF PEMETREXED PLUS PLATINUM AND NON-PEMETREXED PLUS PLATINUM AS 1ST LINE CHEMOTHERAPY IN EGFR WILD TYPE NON-SQUAMOUS NSCLC
    Kang, E. J.
    Lee, S. Y.
    Kim, J. S.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [3] Sintilimab plus platinum-based chemotherapy for non-squamous NSCLC
    Venkatesan, Priya
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E76 - E76
  • [4] Health-Related Quality of Life with Pembrolizumab or Placebo plus Pemetrexed plus Platinum in Non-Squamous NSCLC: KEYNOTE-189
    Garassino, M.
    Rodriguez-Abreu, D.
    Gadgeel, S.
    Esteban, E.
    Felip, E.
    Speranza, G.
    Domine, M.
    Hochmair, M.
    Powell, S.
    Cheng, S.
    Bischoff, H.
    Peled, N.
    Reck, M.
    Hui, R.
    Garon, E.
    Boyer, M.
    Yang, J.
    Burke, T.
    Pietanza, M. C.
    Gandhi, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S155 - S155
  • [5] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [6] ORIENT-11: Sintilimab plus Pemetrexed plus Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC
    Zhang, L.
    Yang, Y.
    Wang, Z.
    Fang, J.
    Yu, Q.
    Han, B.
    Cang, S.
    Chen, G.
    Mei, X.
    Yang, Z.
    Ma, R.
    Bi, M.
    Ren, X.
    Zhou, J.
    Li, B.
    Xu, W.
    Ji, Y.
    Peng, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (10) : E41 - E41
  • [7] BR-34-Randomized Trial of Durvalumab and Tremelimumab plus /- Platinum Chemotherapy in Patients with Metastatic Squamous or Non-Squamous NSCLC
    Kulkarni, S.
    Laurie, S.
    Goss, G.
    Perrone, F.
    Hughes, B.
    Pavlakis, N.
    Stockler, M.
    Blais, A.
    Zibdawi, L.
    Vera-Badillo, F.
    Leighl, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S480 - S481
  • [8] RANDOMIZED STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN NON-SQUAMOUS NSCLC (LOGIK0904)
    Moriwaki, Atsushi
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    [J]. RESPIROLOGY, 2013, 18 : 27 - 27
  • [9] A Phase II Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed in Elderly Patients with Advanced Non-Squamous NSCLC
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Goto, Koichi
    Yoh, Kiyotaka
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Tanaka, Hiroshi
    Abe, Tetsuya
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S316 - S316
  • [10] EFFICACY AND SURVIVAL DATA FROM A PHASE II STUDY OF HISTOLOGY-GUIDED CHEMOTHERAPY IN STAGE IIIB/IV NON-SMALL CELL LUNG CANCER WITH PEMETREXED PLUS PLATINUM FOR NON-SQUAMOUS AND TAXANE PLUS PLATINUM FOR SQUAMOUS AND NON-SQUAMOUS CARCINOMAS
    Sunpaweravong, Patrapim
    Dechaphunkul, Arunee
    Nirattisaikul, Sitang
    Kayasuy, Kanita
    Viriyachaiyo, Vilaiwan
    Juthong, Siwasak
    Keeratichananont, Warangkana
    Navasakulpong, Asma
    Kamonmarttayakul, Katekanok
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1315 - S1315
12345